Methods, compositions, and kits for treating, modulating, or preventing angiogenesis or fibrosis in a subject's eye using a galectin protein inhibitor

摘要

Methods and kits using a pharmaceutical composition for use in inhibiting ocular angiogenesis or fibrosis are provided herein, such that composition includes a pharmaceutically suitable carrier or diluent and an amount of the inhibitor composition effective to inhibit the angiogenesis or the fibrosis by inhibiting expression and/or activity of a galectin protein or a portion thereof.